Skip to main content
U.S. Department of Health and Human Services
—
National Institutes of Health
Create Account
Login
Main menu
Discover
Share
Create
Learn
Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) AMP catalytic product complex
Autogenerated by
for
aeks
Created on Fri, 2022-06-17 07:53, last updated on Fri, 2022-06-17 07:53
I Printed This
Remix It
Vertical Tabs
General Information
This Model was autogenerated from the
"Quick Submit"
tool.
Model ID
3DPX-017248
Category
Proteins, Macromolecules and Viruses
Keyword(s)
HINT, histidine triad, HIT, HYDROLASE
Protein Data Bank ID
5KLZ
Experimental Method
X-RAY DIFFRACTION
Resolution
1.500
Model Details
Associated Species
Escherichia coli
Oligomeric Details
dimeric
R-Factor
0.1652
Scattering Type
x-ray
Attribution
PubMed ID
28 968 488
Digital Object Identifier (DOI)
10.1021/acs.molpharmaceut.7b00664
Citation Title
A Crystal Structure Based Guide to the Design of Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) Activated ProTides.
Journal
Mol. Pharm.
Citation Year
2017
STL/VRML Files
PDB-5KLZ-ribbon-secondary.wrl
PDB-5KLZ-ribbon-rainbow.wrl
PDB-5KLZ-ribbon-bychain.wrl
PDB-5KLZ-ribbon.stl
PDB-5KLZ-surf-bychain.wrl
PDB-5KLZ-surf-hydropathy.wrl
PDB-5KLZ-surf-coulombic.wrl
PDB-5KLZ-surf.stl
PDB-5KLZ.zip
X3D Files
PDB-5KLZ-ribbon-secondary.x3d
PDB-5KLZ-ribbon-rainbow.x3d
PDB-5KLZ-ribbon-bychain.x3d
PDB-5KLZ-ribbon.x3d
PDB-5KLZ-surf-bychain.x3d
PDB-5KLZ-surf-hydropathy.x3d
PDB-5KLZ-surf-coulombic.x3d
PDB-5KLZ-surf.x3d
Rating
Select rating
Give Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) AMP catalytic product complex 1/5
Give Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) AMP catalytic product complex 2/5
Give Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) AMP catalytic product complex 3/5
Give Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) AMP catalytic product complex 4/5
Give Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) AMP catalytic product complex 5/5
Cancel rating
No votes yet
Licensing
Comments
0